Cyramza

121,01 252,10 

Therapeutic VEGFR2-antibody from the original Cyramza commercial drug targeting the VEGFR2-antigen, also referred to as Cyramza antibody.

Category Product Concentration [mg/mL] Volume per Vial [µL] Quantity per vial [mg] Batch Number Manufacturing Year PriceQuantityTotal
aliquot 102002C5958452015 121,01 
-
+
121,01 
spinner
aliquot 102002C7166032015 121,01 
-
+
121,01 
spinner
aliquot 102002C7767062015 121,01 
-
+
121,01 
spinner
aliquot 102002C8260122016 121,01 
-
+
121,01 
spinner
aliquot 102002C8567072016 121,01 
-
+
121,01 
spinner
aliquot 102002C8892142017 121,01 
-
+
121,01 
spinner
dilution11000,1-2015 252,10 
-
+
252,10 
spinner

Category: SKU: N/A

Description

Additional information

Category

aliquot, dilution

Therapeutic molecule

Ramucirumab

Antigen

VEGFR2

Product Concentration [mg/mL]

1, 10

Volume per Vial [µL]

100, 200

Quantity per vial [mg]

0, 0,1, 2

Batch Number

NOT APPLICABLE, C595845, C716603, C776706, C826012, C856707, C889214, –

Manufacturing Year

2015, 2016, 2017